ITBO970064A0 - Uso della rifaximina e delle composizioni farmaceutiche che la conteng ono nel trattamento della diarrea da criptosporidiosi. - Google Patents

Uso della rifaximina e delle composizioni farmaceutiche che la conteng ono nel trattamento della diarrea da criptosporidiosi.

Info

Publication number
ITBO970064A0
ITBO970064A0 IT97BO000064A ITBO970064A ITBO970064A0 IT BO970064 A0 ITBO970064 A0 IT BO970064A0 IT 97BO000064 A IT97BO000064 A IT 97BO000064A IT BO970064 A ITBO970064 A IT BO970064A IT BO970064 A0 ITBO970064 A0 IT BO970064A0
Authority
IT
Italy
Prior art keywords
cryptosporidiosic
rifaximin
diarrhea
contain
treatment
Prior art date
Application number
IT97BO000064A
Other languages
English (en)
Inventor
Patrizio Ferrari
Antonella Ferrieri
Pietro Caramello
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO970064A0 publication Critical patent/ITBO970064A0/it
Priority to IT97BO000064A priority Critical patent/IT1290679B1/it
Priority to DE69805672T priority patent/DE69805672T2/de
Priority to PT98101081T priority patent/PT858804E/pt
Priority to EP98101081A priority patent/EP0858804B1/en
Priority to HU9800115A priority patent/HU224592B1/hu
Priority to DK98101081T priority patent/DK0858804T3/da
Priority to ES98101081T priority patent/ES2178048T3/es
Priority to AT98101081T priority patent/ATE218342T1/de
Priority to US09/013,655 priority patent/US5886002A/en
Priority to JP02981398A priority patent/JP4848083B2/ja
Priority to KR10-1998-0004389A priority patent/KR100436243B1/ko
Priority to CN98106920A priority patent/CN1115146C/zh
Publication of ITBO970064A1 publication Critical patent/ITBO970064A1/it
Application granted granted Critical
Publication of IT1290679B1 publication Critical patent/IT1290679B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
IT97BO000064A 1997-02-14 1997-02-14 Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. IT1290679B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT97BO000064A IT1290679B1 (it) 1997-02-14 1997-02-14 Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.
ES98101081T ES2178048T3 (es) 1997-02-14 1998-01-22 Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
PT98101081T PT858804E (pt) 1997-02-14 1998-01-22 Utilizacao de rifaximina como medicamento para o tratamento da diarreia de crisptosporidiose
EP98101081A EP0858804B1 (en) 1997-02-14 1998-01-22 Use of rifaximin as medicament for the treatment of the diarrhoea from cryptosporidiosis
HU9800115A HU224592B1 (hu) 1997-02-14 1998-01-22 Rifaximin alkalmazása kriptosporidiózis következtében fellépő hasmenés kezelésére használható gyógyszerkészítmény előállítására
DK98101081T DK0858804T3 (da) 1997-02-14 1998-01-22 Anvendelse af rifaximin og farmaceutiske præparater indeholdende dette i behandlingen af diarré forårsaget af cryptosporidiosis
DE69805672T DE69805672T2 (de) 1997-02-14 1998-01-22 Verwendung von Rifaximin als Medikament zur Behandlung von durch Cryptosporidiose verursachten Diarrhoeen
AT98101081T ATE218342T1 (de) 1997-02-14 1998-01-22 Verwendung von rifaximin als medikament zur behandlung von durch cryptosporidiose verursachten diarrhoeen
US09/013,655 US5886002A (en) 1997-02-14 1998-01-26 Use of rifaximin and of pharmaceutical compositions containing it in the treatment of the diarrhoea from cryptosporidiosis
JP02981398A JP4848083B2 (ja) 1997-02-14 1998-02-12 リファキシミンを有効成分として含有するクリプトスポリジオーシスに起因する下痢を治療するための医薬製剤
KR10-1998-0004389A KR100436243B1 (ko) 1997-02-14 1998-02-13 크립토스포리디오시스성 설사 치료에서의 리팍시민 및 이를함유한 의약 조성물의 용도
CN98106920A CN1115146C (zh) 1997-02-14 1998-02-13 利福昔明在治疗由隐孢子虫病引起的腹泻中的用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97BO000064A IT1290679B1 (it) 1997-02-14 1997-02-14 Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.

Publications (3)

Publication Number Publication Date
ITBO970064A0 true ITBO970064A0 (it) 1997-02-14
ITBO970064A1 ITBO970064A1 (it) 1998-08-14
IT1290679B1 IT1290679B1 (it) 1998-12-10

Family

ID=11341939

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97BO000064A IT1290679B1 (it) 1997-02-14 1997-02-14 Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.

Country Status (12)

Country Link
US (1) US5886002A (it)
EP (1) EP0858804B1 (it)
JP (1) JP4848083B2 (it)
KR (1) KR100436243B1 (it)
CN (1) CN1115146C (it)
AT (1) ATE218342T1 (it)
DE (1) DE69805672T2 (it)
DK (1) DK0858804T3 (it)
ES (1) ES2178048T3 (it)
HU (1) HU224592B1 (it)
IT (1) IT1290679B1 (it)
PT (1) PT858804E (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO2004099168A2 (en) * 2003-04-30 2004-11-18 The Institutes For Pharmaceutical Discovery, Llc Substituted carboxylic acids
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
JP5844961B2 (ja) * 2006-08-02 2016-01-20 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線直腸ｓ状結腸炎を処置するための組成物および方法
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
DK2327407T3 (da) * 2008-09-26 2014-08-25 Aska Pharm Co Ltd Profylaktisk og/eller terapeutisk middel til funktionelle gastrointestinale sygdomme
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
SMT202400116T1 (it) 2008-10-02 2024-05-14 Salix Pharmaceuticals Ltd Trattamento dell’encefalopatia epatica utilizzando rifaximina
US20110035232A1 (en) 2008-10-02 2011-02-10 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
RU2012126084A (ru) 2009-11-23 2013-12-27 Сипла Лимитед Пенная композиция для местного применения
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
EP2544660B1 (en) * 2010-03-10 2018-06-13 Lupin Limited Rifaximin ready-to-use suspension
CN103221032A (zh) 2010-09-13 2013-07-24 西普拉有限公司 药物组合物
WO2012076832A1 (en) 2010-12-09 2012-06-14 Cipla Limited Suppositories comprising rifaximin
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
PT3546464T (pt) 2014-05-12 2020-08-05 Alfasigma Spa Preparação e utilização da forma cristalina tau de rifaximina solvatada com degme
CN106999477B (zh) * 2014-06-30 2020-04-10 萨利克斯药品公司 用于重复治疗肠易激综合征(ibs)的方法
US20180021297A1 (en) * 2015-02-26 2018-01-25 Jaguar Health, Inc. Use Of Croton- Or Calophyllum-Derived Proanthocyanidin Polymers Or Botanical Extracts In Combination With Rifaximin For The Treatment Of Diarrhea In Non-Human Animals
JP6817966B2 (ja) * 2015-06-10 2021-01-20 シンロジック オペレーティング カンパニー インコーポレイテッド 高アンモニア血症に関連する疾患を治療するために操作された細菌
EP3525825B1 (en) 2016-10-14 2024-03-20 Cipla Limited Pharmaceutical compositions comprising rifaximin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter

Also Published As

Publication number Publication date
KR100436243B1 (ko) 2004-08-25
HU224592B1 (hu) 2005-11-28
EP0858804B1 (en) 2002-06-05
HUP9800115A3 (en) 2000-04-28
ITBO970064A1 (it) 1998-08-14
HU9800115D0 (en) 1998-03-30
ATE218342T1 (de) 2002-06-15
DE69805672D1 (de) 2002-07-11
PT858804E (pt) 2002-10-31
ES2178048T3 (es) 2002-12-16
US5886002A (en) 1999-03-23
JPH10226645A (ja) 1998-08-25
CN1214244A (zh) 1999-04-21
DE69805672T2 (de) 2003-01-23
HUP9800115A1 (hu) 1999-06-28
JP4848083B2 (ja) 2011-12-28
KR19980071348A (ko) 1998-10-26
IT1290679B1 (it) 1998-12-10
CN1115146C (zh) 2003-07-23
EP0858804A1 (en) 1998-08-19
DK0858804T3 (da) 2002-07-08

Similar Documents

Publication Publication Date Title
BR0211769A (pt) Combinações antineoplásicas
DE69830372D1 (de) Gaserzeugende zusammensetzung und formmasse davon
DE69820231D1 (de) In längsrichtung angeordnete doppelkammerzugangsöffnung
ITBO930099A0 (it) Uso di rifaximin e di formulazioni che la contengono nel trattamen- to delle dispepsie gastriche originate da helicobacter pylori.
CA2429020A1 (en) Use of cci-779 as an antineoplastic agent
BR9707501A (pt) Composto composição farmacêutica e uso do composto
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
BR9707812A (pt) Composto composto farmacêutica e uso do composto
DE69724629D1 (de) Zusammensetzungen und deren verwendungen
TR199800117A3 (tr) Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi.
SE9904377D0 (sv) Pharmaceutical combinations
BR9707808A (pt) Composto composição farmacêutica e uso do composto
BR9811958B1 (pt) uso de um absorvedor de uv derivado de bis(resorcinil)triazina e formulaÇço cosmÉtica compreendendo o mesmo.
ITMI961103A0 (it) Valvola di omogeneizzazione
BR9710894A (pt) V lvula de reten-Æo de duas placas
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
DE69715701D1 (de) Photopolymerisierbare Zusammensetzung und gehärtete, transparente Gegenstände
BR7401412U (pt) Estojo de uso pessoal
NO985079D0 (no) Eksplosiv formulering
NL1007839A1 (nl) Formulering en gebruik.
NO985111D0 (no) Eksplosiv formulering
DE69717186D1 (de) Rückschlagventil
IT1292103B1 (it) Composizioni farmaceutiche topiche contenenti pirfenossone e uso dello stesso nel trattamento di condizioni infiammatorie
KR970059103U (ko) 첵크밸브
DE69725034D1 (de) Diffusionspumpe

Legal Events

Date Code Title Description
0001 Granted